Reghupaty, S.C.; Kanwal, S.; Mendoza, R.G.; Davis, E.; Li, H.; Lai, Z.; Dozmorov, M.G.; Faison, M.O.; Siddiqui, R.A.; Sarkar, D.
Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC). Cancers 2023, 15, 4283.
https://doi.org/10.3390/cancers15174283
AMA Style
Reghupaty SC, Kanwal S, Mendoza RG, Davis E, Li H, Lai Z, Dozmorov MG, Faison MO, Siddiqui RA, Sarkar D.
Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC). Cancers. 2023; 15(17):4283.
https://doi.org/10.3390/cancers15174283
Chicago/Turabian Style
Reghupaty, Saranya Chidambaranathan, Sadia Kanwal, Rachel G. Mendoza, Eva Davis, Haiwen Li, Zhao Lai, Mikhail G. Dozmorov, Milton Omar Faison, Rafat Ali Siddiqui, and Devanand Sarkar.
2023. "Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC)" Cancers 15, no. 17: 4283.
https://doi.org/10.3390/cancers15174283
APA Style
Reghupaty, S. C., Kanwal, S., Mendoza, R. G., Davis, E., Li, H., Lai, Z., Dozmorov, M. G., Faison, M. O., Siddiqui, R. A., & Sarkar, D.
(2023). Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC). Cancers, 15(17), 4283.
https://doi.org/10.3390/cancers15174283